Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12534610.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sarcoidosis is an inflammatory disease with potentially severe mucocutaneous manifestations. Mycophenolate mofetil (MMF) is an immunosuppressive drug extensively used in organ transplantation. Its use has been rapidly expanded into autoimmune and inflammatory diseases. We report the first successful and safe use of MMF in five patients with sarcoidosis.
Medical subject headings
- Dermatologic Agents
- Immunosuppressive Agents
- Mycophenolic Acid
- Sarcoidosis
- Skin Diseases